Boundless Bio has announced a strategic portfolio prioritization aimed at optimizing its oncology programs, particularly focusing on the combination therapy of BBI-355 and BBI-825, alongside a new ...

Tonix Pharmaceuticals CEO Seth Lederman joins Proactive's Natalie Stoberman to announce the acquisition of Healion Bio, including its entire portfolio of next-generation antiviral technology ...

Biogen has agreed to pay at least $1.15 billion for biotech firm Human Immunology Biosciences (HI-Bio) as it moves to increase its immunology portfolio. The deal includes the possibility of an ...

GSK on Tuesday said it would acquire asthma drug maker Aiolos Bio in a deal worth up to $1.4 billion, as the British drugmaker boosts its growing respiratory diseases portfolio.